César Cuero, Edgar Delgado, Mitzi de González, Clarisa Medina, Alejandro Vernaza, Juan Moscoso
{"title":"[C0 / C2水平及其在肾移植中的意义]。","authors":"César Cuero, Edgar Delgado, Mitzi de González, Clarisa Medina, Alejandro Vernaza, Juan Moscoso","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We present a trial consisting of 52 kidney transplant patients with stable function, following a transplantation period of 3-6 months (group1), 6-12 months (group2) and more than 12 months (group3) and monitored by CO, C2 and Cyclosporine levels in blood. Mean serum creatinine level were in 1.1, 1.3 and 1.4 Mg/dl for group 1, 2 and 3 respectively. Mean Neoral doses (mg/kg/day) were 5.5, 4.4 and 3.0 for each group respectively. Mean CO (ng/ml) was 347.6 (group 1), 265.6 (group 2) and 207.6 (group 3), and mean C2 was 1353.5, 1098 and 904.2 for each group. 40% (2/5patients) from group2 and 41% (17/41patients) for group 3, had overexposure of the graft to Neoral; meantime 24% (10/41 patients) from group 3 shown C2 levels of underexposure. We conclude CO is a poor predictor of graft exposition to cyclosporine and C2 reflect more exactly this exposure.</p>","PeriodicalId":21235,"journal":{"name":"Revista medica de Panama","volume":"27 ","pages":"30-3"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[C0 vs C2 levels and their implications in kidney transplantation].\",\"authors\":\"César Cuero, Edgar Delgado, Mitzi de González, Clarisa Medina, Alejandro Vernaza, Juan Moscoso\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We present a trial consisting of 52 kidney transplant patients with stable function, following a transplantation period of 3-6 months (group1), 6-12 months (group2) and more than 12 months (group3) and monitored by CO, C2 and Cyclosporine levels in blood. Mean serum creatinine level were in 1.1, 1.3 and 1.4 Mg/dl for group 1, 2 and 3 respectively. Mean Neoral doses (mg/kg/day) were 5.5, 4.4 and 3.0 for each group respectively. Mean CO (ng/ml) was 347.6 (group 1), 265.6 (group 2) and 207.6 (group 3), and mean C2 was 1353.5, 1098 and 904.2 for each group. 40% (2/5patients) from group2 and 41% (17/41patients) for group 3, had overexposure of the graft to Neoral; meantime 24% (10/41 patients) from group 3 shown C2 levels of underexposure. We conclude CO is a poor predictor of graft exposition to cyclosporine and C2 reflect more exactly this exposure.</p>\",\"PeriodicalId\":21235,\"journal\":{\"name\":\"Revista medica de Panama\",\"volume\":\"27 \",\"pages\":\"30-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista medica de Panama\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Panama","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[C0 vs C2 levels and their implications in kidney transplantation].
We present a trial consisting of 52 kidney transplant patients with stable function, following a transplantation period of 3-6 months (group1), 6-12 months (group2) and more than 12 months (group3) and monitored by CO, C2 and Cyclosporine levels in blood. Mean serum creatinine level were in 1.1, 1.3 and 1.4 Mg/dl for group 1, 2 and 3 respectively. Mean Neoral doses (mg/kg/day) were 5.5, 4.4 and 3.0 for each group respectively. Mean CO (ng/ml) was 347.6 (group 1), 265.6 (group 2) and 207.6 (group 3), and mean C2 was 1353.5, 1098 and 904.2 for each group. 40% (2/5patients) from group2 and 41% (17/41patients) for group 3, had overexposure of the graft to Neoral; meantime 24% (10/41 patients) from group 3 shown C2 levels of underexposure. We conclude CO is a poor predictor of graft exposition to cyclosporine and C2 reflect more exactly this exposure.